1. Home
  2. CVKD vs EPOW Comparison

CVKD vs EPOW Comparison

Compare CVKD & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • EPOW
  • Stock Information
  • Founded
  • CVKD 2022
  • EPOW 2014
  • Country
  • CVKD United States
  • EPOW China
  • Employees
  • CVKD N/A
  • EPOW N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • EPOW Business Services
  • Sector
  • CVKD Health Care
  • EPOW Consumer Discretionary
  • Exchange
  • CVKD Nasdaq
  • EPOW Nasdaq
  • Market Cap
  • CVKD 29.5M
  • EPOW 24.5M
  • IPO Year
  • CVKD 2023
  • EPOW 2021
  • Fundamental
  • Price
  • CVKD $13.18
  • EPOW $1.03
  • Analyst Decision
  • CVKD Strong Buy
  • EPOW
  • Analyst Count
  • CVKD 1
  • EPOW 0
  • Target Price
  • CVKD $32.00
  • EPOW N/A
  • AVG Volume (30 Days)
  • CVKD 34.8K
  • EPOW 12.0K
  • Earning Date
  • CVKD 08-06-2025
  • EPOW 07-15-2025
  • Dividend Yield
  • CVKD N/A
  • EPOW N/A
  • EPS Growth
  • CVKD N/A
  • EPOW N/A
  • EPS
  • CVKD N/A
  • EPOW N/A
  • Revenue
  • CVKD N/A
  • EPOW $64,997,741.00
  • Revenue This Year
  • CVKD N/A
  • EPOW N/A
  • Revenue Next Year
  • CVKD N/A
  • EPOW N/A
  • P/E Ratio
  • CVKD N/A
  • EPOW N/A
  • Revenue Growth
  • CVKD N/A
  • EPOW 44.28
  • 52 Week Low
  • CVKD $5.70
  • EPOW $0.55
  • 52 Week High
  • CVKD $22.90
  • EPOW $1.36
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 51.34
  • EPOW 61.61
  • Support Level
  • CVKD $11.00
  • EPOW $0.92
  • Resistance Level
  • CVKD $13.56
  • EPOW $0.96
  • Average True Range (ATR)
  • CVKD 1.11
  • EPOW 0.05
  • MACD
  • CVKD 0.26
  • EPOW 0.01
  • Stochastic Oscillator
  • CVKD 85.72
  • EPOW 96.67

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About EPOW Sunrise New Energy Co. Ltd

Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.

Share on Social Networks: